Loading organizations...
Loading organizations...
End-to-end software platform for managing clinical trial operations.
Strategikon Pharma has raised $7.0M across 1 funding round.
Strategikon Pharma has raised $7.0M in total across 1 funding round.
Strategikon Pharma has raised $7.0M in total across 1 funding round.
Strategikon Pharma's investors include Vincent Lepreux, Debra Kemper, Beth Devin, Nate Lentz.
Strategikon Pharma has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series A in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 6, 2024 | $7.0M Series A | Vincent Lepreux, Debra Kemper, Beth Devin, Nate Lentz |